Neyran Kertmen

793 citations
57 papers · 527 · h-index 11

Impact in

  • Oncology top 10%
    • Cancer Risks and Factors
    • COVID-19 and healthcare impacts
    • HER2/EGFR in Cancer Research
    • Cancer Cells and Metastasis
    • Global Cancer Incidence and Screening
    • Cancer Immunotherapy and Biomarkers
    • Breast Cancer Treatment Studies

Papers in

    • Cancer Treatment and Pharmacology 5
    • Cancer Risks and Factors 5
    • Cancer Diagnosis and Treatment 4
    • HER2/EGFR in Cancer Research 3
    • Glioma Diagnosis and Treatment 6

Neyran Kertmen

53 papers receiving 502 citations

Peers

Neyran Kertmen
Comparison fields: 5 of 81
  • Oncology 256
  • Cancer Research 103
  • Internal Medicine 11
  • Applied Microbiology and Biotechnology 4
  • Pulmonary and Respiratory Medicine 60
Replace Athina Stravodimou with:
Athina Stravodimou Switzerland
Michiel Strijbos Belgium
Mónica Tang Australia
Annelie Liljegren Sweden
Weijiang Liang China
Mads Nordahl Svendsen Denmark
Furkan Sarici Türkiye
Alex Siu Wing Chan Hong Kong
Oliver Higuera Spain
PA Ganz United States
Neyran Kertmen relative to Athina Stravodimou Switzerland Athina Stravodimou's profile →
Citations per field
00.5×
Athina Stravodimou · 1×
Citations per year

Countries citing papers authored by Neyran Kertmen

Since Specialization
Citations

This map shows the geographic impact of Neyran Kertmen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neyran Kertmen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neyran Kertmen more than expected).

Fields of papers citing papers by Neyran Kertmen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neyran Kertmen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neyran Kertmen. The network helps show where Neyran Kertmen may publish in the future.

Co-authors

The 25 scholars most cited alongside Neyran Kertmen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neyran Kertmen Line = papers co-authored together Neyran Kertmen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2012134
2
The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
201355
3 201645
4 202128
5 202127
6 202026
7
The lymph node ratio as an independent prognostic factor for non-metastatic node-positive breast cancer recurrence and mortality.
201521
8
Molecular subtypes in patients with inflammatory breast cancer; a single center experience.
201517
9 202115
10
The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients.
201511
11 202111
12
Impact of the obesity on lymph node status in operable breast cancer patients.
201410
13 20218
14 20158
15 20217
16
Which sequence best protects the heart against trastuzumab and anthracycline toxicity? An electron microscopy study in rats.
20157
17
Efficacy and safety of eribulin monotherapy in patients with heavily pretreated metastatic breast cancer.
20167
18 20236
19 20226
20 20156

About Neyran Kertmen

Neyran Kertmen is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Cancer Research and Hematology, having authored 57 papers that have together received 527 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Glioma Diagnosis and Treatment (6 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Risks and Factors (5 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cancer Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (4 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (256 citations), Cancer Research (103 citations), Internal Medicine (11 citations), Applied Microbiology and Biotechnology (4 citations) and Pulmonary and Respiratory Medicine (60 citations). Neyran Kertmen has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Kadri Altundağ, Taner Babacan, Furkan Sarici, Zafer Arık, Özge Keskin, Mustafa Solak, Fatma Paksoy Türköz, İbrahim Petekkaya, Sercan Aksoy and Yavuz Özışık. Their work appears in journals such as Journal of Clinical Oncology, BMJ Supportive & Palliative Care, Future Oncology, Annals of Oncology and Cancer Control.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact